Related references
Note: Only part of the references are listed.Comparing Lean and Obese PCOS in Different PCOS Phenotypes: Evidence That the Body Weight Is More Important than the Rotterdam Phenotype in Influencing the Metabolic Status
Enrico Carmina et al.
DIAGNOSTICS (2022)
Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily
Enrico Carmina et al.
CLINICAL ENDOCRINOLOGY (2019)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
FERTILITY AND STERILITY (2018)
Polycystic ovary syndrome
Ricardo Azziz et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Prevalence of metabolic syndrome in women with polycystic ovary syndrome
Dimitrios Panidis et al.
CLINICAL ENDOCRINOLOGY (2013)
Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics
Seda Ates et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
Bart C. J. M. Fauser et al.
FERTILITY AND STERILITY (2012)
Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study
Dimitrios Panidis et al.
HUMAN REPRODUCTION (2012)
Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria
Bulent Okan Yildiz et al.
HUMAN REPRODUCTION (2012)
Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria
Mehmet Yilmaz et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2011)
Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
Ettore Guastella et al.
FERTILITY AND STERILITY (2010)
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Robert A. Wild et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome
P. A. Essah et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Position statement: Glucose intolerance in polycystic ovary syndrome - A position statement of the androgen excess society
Kelsey E. S. Salley et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria
Rupal Shroff et al.
FERTILITY AND STERILITY (2007)
Diagnosis, phenotype, and prevalence of polycystic ovary syndrome
Enrico Carmina et al.
FERTILITY AND STERILITY (2006)
Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters
E Carmina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
BCJM Fauser et al.
HUMAN REPRODUCTION (2004)
Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet
E Carmina et al.
HUMAN REPRODUCTION (2003)
Share Paper
